# FDA recall D-1142-2017

> **Andropharm, LLC** · Class I · drug recall initiated 2017-06-06.

## Product

ANDROPHARM STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a, 17b-dimethyl-5a-androstan-3-one azine 10 mg) capsule, packaged in 60-count bottle, Andropharm.com, UPC: 6 42125 50294 8

## Reason for recall

Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.

## Distribution

Florida

## Key facts

- **Recall number:** D-1142-2017
- **Recalling firm:** Andropharm, LLC
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-06-06
- **Report date:** 2017-09-20
- **Termination date:** 2020-06-02

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Boca Raton, FL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1142-2017

## Citation

> AI Analytics. FDA recall D-1142-2017. Retrieved 2026-07-20 from https://api.ai-analytics.org/recall/D-1142-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*